Eye cancer articles from across Nature Portfolio

Eye cancer is an uncommon tumour that can affect the outer parts of the eye (like the eyelid) or the inside of the eyeball (intraocular cancer). The most common intraocular cancers in adults are melanoma and lymphoma, whereas the most common in children is retinoblastoma, which starts in cells of the retina.

Latest Research and Reviews

Research
13 March 2023 | Open Access

Differentiating malignant and benign eyelid lesions using deep learning
- Min Joung Lee
- , Min Kyu Yang
- & Bum-Joo Cho
Scientific Reports 13, 4103
Research | 24 February 2023

Long-term outcomes of margin-controlled excision for eyelid melanoma
- John C. Bladen
- , Raman Malhotra
- & Andre Litwin
Eye, 1-5
Research
17 February 2023 | Open Access

Amniotic membrane application in surgical treatment of conjunctival tumors
- Alena Furdova
- , Gabriela Czanner
- & Zuzana Pridavkova
Scientific Reports 13, 2835
Reviews | 08 February 2023

Medical treatment for ocular surface squamous neoplasia
- David Monroy
- , Andres Serrano
- & Carol L. Karp
Eye, 1-9
Research | 23 January 2023

Primary cemiplimab treatment for orbital squamous cell carcinoma is effective and may alleviate the need for orbital exenteration
- Alon Tiosano
- , Meydan Ben-Ishai
- & Iftach Yassur
Eye, 1-6
Research
19 January 2023 | Open Access

A joinpoint and age–period–cohort analysis of ocular cancer secular trends in Iran from 2004 to 2016
- Mohammad Abolhosseini
- , Zahra Khorrami
- & Saeed Karimi
Scientific Reports 13, 1074

All Research & Reviews

News and Comment

Editorial | 01 March 2023

LXS196 for Metastatic Uveal Melanoma - finally some progress

Metastatic uveal melanoma continues to have a poor prognosis with distinct pathophysiology from cutaneous melanoma and limited effective treatment options. Targeted therapy with darovasertib towards protein kinase C is well tolerated with signals of early efficacy, warranting further exploration and combination strategies.
- A. Rodrigues
- , R. Cosman
- & A. M. Joshua
British Journal of Cancer, 1-3
Editorial | 13 December 2022

Ocular oncology demystified
- Vikas Chadha
- & Mandeep S Sagoo
Eye, 1-2
Correspondence | 17 September 2022

Comment on: Refractory full thickness macular hole: current surgical management
- Víctor Manuel Asensio-Sánchez
Eye 37, 376
Correspondence | 13 April 2022

Looking through the scope: retinoblastoma in the Philippines
- Ma. Carmela B. Guevarra
- , Michelle Ann B. Eala
- & Edward Ryan A. Collantes
Eye 36, 2356-2357
Correspondence | 18 November 2021

Vitreoretinal lymphoma: an alternative view
- Bertil Damato
Eye 36, 1845
Research Highlights | 08 October 2021

Tebentafusp for uveal melanoma
- David Killock
Nature Reviews Clinical Oncology 18, 747

All News & Comment

Eye cancer articles from across Nature Portfolio

Latest Research and Reviews

Differentiating malignant and benign eyelid lesions using deep learning

Long-term outcomes of margin-controlled excision for eyelid melanoma

Amniotic membrane application in surgical treatment of conjunctival tumors

Medical treatment for ocular surface squamous neoplasia

Primary cemiplimab treatment for orbital squamous cell carcinoma is effective and may alleviate the need for orbital exenteration

A joinpoint and age–period–cohort analysis of ocular cancer secular trends in Iran from 2004 to 2016

News and Comment

LXS196 for Metastatic Uveal Melanoma - finally some progress

Ocular oncology demystified

Comment on: Refractory full thickness macular hole: current surgical management

Looking through the scope: retinoblastoma in the Philippines

Vitreoretinal lymphoma: an alternative view

Tebentafusp for uveal melanoma

Search

Quick links